BioXcel Therapeutics (BTAI) Restructuring Costs (2023 - 2025)
BioXcel Therapeutics (BTAI) posted quarterly Restructuring Costs of $194000.0 for Q3 2025, down 87.51% year-over-year from $1.6 million in Q3 2024, and up 487.88% quarter-over-quarter from $33000.0 in Q4 2024.
BioXcel Therapeutics (BTAI) Restructuring Costs (2023 - 2025) Analysis & Trends
BioXcel Therapeutics' Restructuring Costs history runs 3 years deep, the most recent figure standing at $194000.0 for Q3 2025.
- In Q3 2025, Restructuring Costs fell 87.51% year-over-year to $194000.0; the TTM figure through Dec 2025 stood at $227000.0 (down 90.7% YoY), while the FY2025 annual figure was $194000.0, down 92.05% from the prior year.
- Restructuring Costs for Q3 2025 stood at $194000.0, up from $33000.0 in the prior quarter.
- The five-year high for Restructuring Costs was $4.2 million in Q3 2023, with the low at $33000.0 in Q4 2024.
- The 3-year median for Restructuring Costs is $856000.0 (2024), against an average of $1.4 million.
- The sharpest annual moves came in 2024 and 2025: Restructuring Costs sank 62.7% in 2024, then slumped 87.51% in 2025.
- BioXcel Therapeutics' Restructuring Costs stood at $4.2 million in 2023, then tumbled by 99.21% to $33000.0 in 2024, then jumped by 487.88% to $194000.0 in 2025.
- Business Quant data shows BTAI's Restructuring Costs at $194000.0 in Q3 2025, $33000.0 in Q4 2024, and $1.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | BioXcel Therapeutics | 24.50 Mn | 24.50 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 194,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 856,000.00 |
| Sep 30, 2023 | 4.16 Mn |